CNBC's Disruptor 50 list for 2024 includes seven healthcare companies out of the finalists selected through nominations for companies founded post-Jan. 1, 2009. Evaluations were based on scalability, user growth, sales growth, and the implementation of breakthrough technologies like AI and machine learning. The advisory board, comprising 50 innovators and entrepreneurs, and venture capitalists conducted both quantitative and qualitative reviews. The list is led by OpenAI, recognized for its growing role in healthcare through Microsoft. Other notable healthcare startups making the list are ElevateBio, Transcarent, Generate:Biomedicines, Alto Pharmacy, Spring Health, Maven Clinic, and Cityblock.
